{"schema_version":"secwatch.filing_event.v1","accession":"0001438533-23-000041","form_type":"8-K/A","ticker":"TVTX","cik":"0001438533","company_name":"Travere Therapeutics, Inc.","filed_at":"2023-09-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.927272+00:00","generated_at":"2026-06-10T22:41:32.152731+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Travere completes asset sale to Mirum for up to $445M; pro forma shows reduced continuing ops revenue","bullets":["Net cash proceeds of $210M at close plus up to $235M in milestones from sale of Chenodal/Cholbam to Mirum; estimated gain of $235M.","Pro forma continuing ops revenue for H1 2023: $63M (down from $116.7M), net loss $198.6M, EPS ($2.75).","Pro forma continuing ops revenue for FY2022: $109.5M (down from $212M), net loss $329.8M, EPS ($5.17).","Pro forma balance sheet at June 30, 2023: cash $277M, total assets $897M, equity $348M.","Milestone payments of up to $235M tied to annual net sales thresholds of $125M-$500M for divested products."],"urls":{"canonical":"https://secwatch.observer/filing/0001438533-23-000041","json":"https://secwatch.observer/filing/0001438533-23-000041.json","markdown":"https://secwatch.observer/filing/0001438533-23-000041.md","text":"https://secwatch.observer/filing/0001438533-23-000041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1438533/000143853323000041/0001438533-23-000041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1438533/000143853323000041/tvtx-20230831.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T22:41:32.152731+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}